There is a 2% rate of post-discharge symptomatic DVT if prophylaxis is used for 7 to 10 days after surgery. There is a 0.1% rate of post-discharge fatal PE at 90 days post-operative if prophylaxis ...

Bristol-Myers Squibb and Pfizer announced that the FDA has approved apixaban for the prophylaxis of deep vein thrombosis in patients who have had hip or knee replacement surgery. Apixaban (Eliquis ...

The FDA has accepted Bristol-Myers Squibb's and Pfizer's supplemental New Drug Application for Eliquis (apixaban), an oral direct Factor Xa inhibitor for prophylaxis of deep vein thrombosis (DVT ...

Without thromboprophylaxis, 45%-57% of patients who have undergone total hip replacement (THR) and 40%-84% of patients who have had total knee replacement (TKR) experience deep venous thrombosis ...

DVT prevalence for total hip arthroplasty, total knee arthroplasty and hip fracture surgery ranges from 50% to 60% in the seven to 14 day post-operative period. 2 ...

The drug is a preventive treatment for deep vein thrombosis, which can lead to pulmonary embolism for patients who have had hip or knee replacement surgery. FDA approves Eliquis for DVT ...

The continuum from surgery to home: Key thoughts on post-orthopedic surgery DVT Healthcare is trending toward outpatient procedures, and technological advancements in surgical technique and pain ...

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for Eliquis (apixaban) for the ...

ThromboGenics NV and co-development partner BioInvent International announce that the first patient has been enrolled in the Phase II trial with their long-acting anticoagulant TB-402 for the ...

DVT prophylaxis reduces the risk of developing deep vein thrombosis through medications, compression stockings, and devices. Deep vein thrombosis (DVT) can occur when a blood clot forms in a deep ...

DVT Prophylaxis - DVT Prophylaxis After Total Joint Arthroplasty. MedGenMed 1(1), 1999 [formerly published in Medscape Orthopaedics & Sports Medicine eJournal 2(6), 1998]. Available at: https ...